Published in J Exp Med on October 01, 1979
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells. Proc Natl Acad Sci U S A (1985) 1.13
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci (2012) 0.99
Biochemical studies on cell fusion. II. Control of fusion response by lipid alteration. J Cell Biol (1985) 0.92
Selective phosphorylation of the IgE receptor in antigen-stimulated rat mast cells. Proc Natl Acad Sci U S A (1983) 0.84
Temporal regulation of the IgE-dependent 1,2-diacylglycerol production by tyrosine kinase activation in a rat (RBL 2H3) mast-cell line. Biochem J (1994) 0.83
Antigen-stimulated metabolism of inositol phospholipids in the cloned murine mast-cell line MC9. Biochem J (1986) 0.83
Characterization of phosphoinositide-specific phospholipase C from human platelets. Biochem J (1987) 0.82
Neuroimmunophysiology of the gastrointestinal mucosa: implications for inflammatory diseases. Trans Am Clin Climatol Assoc (1995) 0.78
Mast cells in allergic diseases and mastocytosis. West J Med (1982) 0.78
Evidence for differential activation of arachidonic acid metabolism in formylpeptide- and macrophage-activation-factor-stimulated guinea-pig macrophages. Biochem J (1985) 0.77
Donald Alan Kennerly, MD, PhD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2006) 0.75
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY. Methods Med Res (1964) 5.87
The fusion of erythrocytes by fatty acids, esters, retinol and alpha-tocopherol. Biochem J (1973) 2.54
Positional specificites in phospholipid hydrolyses. Biochemistry (1962) 2.51
Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli. J Immunol (1975) 2.07
Changes in lipid metabolism and cell morphology following attack by phospholipase C (Clostridium perfringens) on red cells or lymphocytes. Biochim Biophys Acta (1975) 1.56
Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J Immunol (1979) 1.54
Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol (1975) 1.52
Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem (1972) 8.24
EXCITATION ENERGY TRANSFER AND THE QUANTITATIVE STUDY OF THE ANTIBODY HAPTEN REACTION. Proc Natl Acad Sci U S A (1960) 4.43
Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A (1979) 3.48
Orbital venous anomalies. Ophthalmology (1997) 3.25
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity (1997) 2.72
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Nontraumatic subperiosteal orbital hemorrhage. Ophthalmology (2001) 2.55
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
Biphasic and protracted anaphylaxis. J Allergy Clin Immunol (1986) 2.36
Illness behavior and the sick role in chronic disease. The case of multiple sclerosis. Soc Sci Med (1982) 2.25
Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol (2001) 2.23
The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev (1996) 2.18
The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest (1968) 2.16
Reactions following intravenous fluorescein. Am J Ophthalmol (1971) 2.13
Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest (1973) 2.09
Biomechanics of baseball pitching. A preliminary report. Am J Sports Med (1985) 2.08
Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli. J Immunol (1975) 2.07
Potentiation of mast cell mediator release by adenosine. J Immunol (1978) 2.05
Radioimmunoassay for prostaglandins. Science (1971) 1.99
Disability resulting from occupational low back pain. Part I: What do we know about primary prevention? A review of the scientific evidence on prevention before disability begins. Spine (Phila Pa 1976) (1996) 1.97
Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants. Plant Physiol (1988) 1.87
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A (1977) 1.86
Quantitation of cytokinins in biological samples using antibodies against zeatin riboside. Plant Physiol (1984) 1.84
Determinants of duration of disability and return-to-work after work-related injury and illness: challenges for future research. Am J Ind Med (2001) 1.79
Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. J Clin Invest (1979) 1.77
Disability resulting from occupational low back pain. Part II: What do we know about secondary prevention? A review of the scientific evidence on prevention after disability begins. Spine (Phila Pa 1976) (1996) 1.76
Transfection of the malaria parasite and expression of firefly luciferase. Proc Natl Acad Sci U S A (1993) 1.70
Lymphocyte activation. Prog Allergy (1976) 1.69
Prostaglandins, macrophages, and immunity. J Immunol (1980) 1.69
Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int Immunol (1996) 1.69
Impact of the national asthma guidelines on internal medicine primary care and specialty practice. Proc (Bayl Univ Med Cent) (2000) 1.66
Preparation and characterization, using high-performance liquid chromatography, of an enzyme forming glucosides of cytokinins. Biochim Biophys Acta (1979) 1.61
Isolation of pure human peripheral blood T-lymphocytes using nylon wool columns. Immunol Commun (1972) 1.58
Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. J Immunol (1977) 1.58
Morphine: radioimmunoassay. Science (1970) 1.56
Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol (1980) 1.55
Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J Immunol (1979) 1.54
Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol (1975) 1.52
Branch retinal artery occlusion in a child. Aust N Z J Ophthalmol (1996) 1.49
Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol (1982) 1.48
Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol (1998) 1.45
Analytic precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol (2000) 1.44
Mutualistic asexual endophytes in a native grass are usually parasitic. Am Nat (2003) 1.44
Floppy eyelid syndrome and mental retardation. Ophthalmology (2000) 1.39
Skin testing to detect penicillin allergy. J Allergy Clin Immunol (1981) 1.37
Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. JAMA (1982) 1.37
Regulators of cell division in plant tissue. XXIII. The identity of an unusual metabolite of 6-benzylaminopurine. Biochim Biophys Acta (1975) 1.36
Drug therapy. During allergy (third of three parts). N Engl J Med (1975) 1.36
Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med (1985) 1.36
Radioimmunoassay for the measurement of cyclic nucleotides. Adv Cyclic Nucleotide Res (1972) 1.29
Squamous cell carcinoma of the eyelids. Br J Ophthalmol (2002) 1.29
Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol (1979) 1.28
Primary localised amyloidosis of the orbit. Br J Ophthalmol (1996) 1.28
Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release. J Immunol (1976) 1.26
Improved radioimaging and tumor localization with monoclonal F(ab')2. J Nucl Med (1983) 1.26
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25
Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol (1997) 1.24
Raphanatin, an unusual purine derivative and a metabolite of zeatin. Biochem Biophys Res Commun (1972) 1.24
Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. J Immunol (1979) 1.23
Fluorescent probes for the study of the antibody-hapten reaction. I. Binding of the 5-dimethylaminonaphthalene-1-sulfonamido group by homologous rabbit antibody. Biochemistry (1967) 1.20
The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. J Immunol (1966) 1.18
Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes. J Exp Med (1983) 1.17
Correlation between mitogenicity and stimulation of calcium uptake in human lymphocytes. Biochem Biophys Res Commun (1974) 1.15
Concanavalin A-induced histamine release from normal rat mast cells. J Immunol (1975) 1.15
The intertrochanteric hip fracture. A retrospective analysis. Orthopedics (1988) 1.14
Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology (2000) 1.13
-Globulin binding of morphine in heroin addicts. J Lab Clin Med (1972) 1.13
Detection of Australia antigen by radioimmunoassay. Proc Natl Acad Sci U S A (1971) 1.13
A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem (1972) 1.12
Immunochemical studies with lysine vasopressin. Endocrinology (1966) 1.12
The effect of Bordetella pertussis on lymphocyte cyclic AMP metabolism. J Exp Med (1973) 1.12
Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol (1982) 1.12
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br J Cancer (2009) 1.12
Alterations in cyclic AMP metabolism in human bronchial asthma. 3. Leukocyte and lymphocyte responses to steroids. J Clin Invest (1973) 1.12
Selective cytotoxicity of hapten-substituted cells with an antibody-enzyme conjugate. J Immunol (1973) 1.11
An indirect pathway of receptor-mediated 1,2-diacylglycerol formation in mast cells. I. IgE receptor-mediated activation of phospholipase D. J Immunol (1990) 1.11
Pathogenesis and management of allergic reactions to penicillin and other beta-lactam antibiotics. Pediatr Infect Dis (1983) 1.10
The rat basophilic leukemia cell receptor for IgE. I. Characterization as a glycoprotein. J Immunol (1976) 1.10
Hydrophobic binding sites on immunoglobulins. Biochemistry (1970) 1.10
The use of protein-substituted nylon catheters for selective immunoadsorption in vivo. J Immunol (1974) 1.08
12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, a chemotactic fatty acid, is incorporated into neutrophil phospholipids and triglyceride. Prostaglandins (1979) 1.07
Prostaglandins and slow-reacting substance. J Allergy Clin Immunol (1979) 1.07
Cyclic AMP and the immune response;. Adv Cyclic Nucleotide Res (1974) 1.07
Opposing effects of mitogenic and nonmitogenic lectins on lymphocyte activation. Evidence that wheat germ agglutinin produces a negative signal. J Biol Chem (1976) 1.07
Large-scale deployment of the Global Trigger Tool across a large hospital system: refinements for the characterisation of adverse events to support patient safety learning opportunities. BMJ Qual Saf (2011) 1.06
Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. Prostaglandins (1980) 1.06
Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol (1986) 1.06